Egalet's IPO

Egalet raised a round of funding on February 06, 2014. Investors include Public.

Egalet is a specialty pharmaceutical company developing and planning to commercialize abuse-deterrent oral products for the treatment of pain and other indications. The company has created two distinc…

Articles about Egalet's IPO: